Cargando…
Evaluation of a low‐dose desoxycorticosterone pivalate treatment protocol for long‐term management of dogs with primary hypoadrenocorticism
BACKGROUND: Lowering the dose of desoxycorticosterone pivalate (DOCP) for the treatment of dogs with primary hypoadrenocorticism (PH) decreases costs and could lead to increased owner motivation to treat their affected dogs. OBJECTIVE: To evaluate the efficacy of a low‐dose DOCP treatment protocol i...
Autores principales: | Sieber‐Ruckstuhl, Nadia S., Reusch, Claudia E., Hofer‐Inteeworn, Nathalie, Kuemmerle‐Fraune, Claudia, Müller, Claudia, Hofmann‐Lehmann, Regina, Boretti, Felicitas S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524388/ https://www.ncbi.nlm.nih.gov/pubmed/30865322 http://dx.doi.org/10.1111/jvim.15475 |
Ejemplares similares
-
Clinical features and long‐term management of cats with primary hypoadrenocorticism using desoxycorticosterone pivalate and prednisolone
por: Sieber‐Ruckstuhl, Nadja S., et al.
Publicado: (2023) -
Desoxycorticosterone Pivalate Duration of Action and Individualized Dosing Intervals in Dogs with Primary Hypoadrenocorticism
por: Jaffey, J.A., et al.
Publicado: (2017) -
Low‐dose desoxycorticosterone pivalate treatment of hypoadrenocorticism in dogs: A randomized controlled clinical trial
por: Vincent, Alysha M., et al.
Publicado: (2021) -
Altered Serum Thyrotropin Concentrations in Dogs with Primary Hypoadrenocorticism before and during Treatment
por: Reusch, C.E., et al.
Publicado: (2017) -
Evaluation of the Cortisol‐to‐ACTH Ratio in Dogs with Hypoadrenocorticism, Dogs with Diseases Mimicking Hypoadrenocorticism and in Healthy Dogs
por: Boretti, F.S., et al.
Publicado: (2015)